Regulation of NO synthesis, local inflammation, and innate: Immunity to pathogens by BET family proteins

Molecular and Cellular Biology

Volumn 34, Issue 3, 2014, Pages 415-427

  Wienerroither, Sebastian ^a   Rauch, Isabella ^a   Rosebrock, Felix ^a   Jamieson, Amanda M ^a   Bradner, James ^b   Muhar, Matthias ^c   Zuber, Johannes ^c   Müller, Mathias ^d   Decker, Thomas ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b HARVARD MEDICAL SCHOOL   (United States)

^c RESEARCH INSTITUTE OF MOLECULAR PATHOLOGY   (Austria)

^d UNIVERSITY OF VETERINARY MEDICINE   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BET PROTEIN; BRD2 PROTEIN; BRD3 PROTEIN; BRD4 PROTEIN; DEXTRAN SULFATE; INDUCIBLE NITRIC OXIDE SYNTHASE; JQ1 PROTEIN; PROTEIN; PROTEIN INHIBITOR; RNA POLYMERASE; SERINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; C TERMINAL DOMAIN; CONTROLLED STUDY; GENE ACTIVITY; GENE EXPRESSION; GENETIC TRANSCRIPTION; IMMUNE RESPONSE; INFLAMMATION; INFLAMMATORY DISEASE; INFLUENZA VIRUS; INNATE IMMUNITY; LISTERIA MONOCYTOGENES; LISTERIOSIS; MACROPHAGE; MACROPHAGE FUNCTION; MOUSE; MURINE MODEL; NONHUMAN; PATHOGENESIS; PHOSPHORYLATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN INTERACTION; TRANSCRIPTION INITIATION;

ANIMALS; AZEPINES; CELLS, CULTURED; GENE EXPRESSION; HOST-PATHOGEN INTERACTIONS; IMMUNITY, INNATE; INFLAMMATION; INFLUENZA A VIRUS, H1N1 SUBTYPE; LISTERIA MONOCYTOGENES; MACROPHAGES; MICE; MICE, INBRED C57BL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; NUCLEAR PROTEINS; ORTHOMYXOVIRIDAE INFECTIONS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTEIN-SERINE-THREONINE KINASES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SURVIVAL ANALYSIS; TRANSCRIPTION FACTORS; TRIAZOLES;

EID: 84892469287     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.01353-13     Document Type: Article

References (79)

1. Kawai T, Akira S. 2009. The roles of TLRs, RLRs and NLRs in pathogen recognition. Int. Immunol. 21:317-337. http://dx.doi.org/10.1093/intimm /dxp017.
2. Iwasaki A, Medzhitov R. 2010. Regulation of adaptive immunity by the innate immune system. Science 327:291-295. http://dx.doi.org/10.1126 /science.1183021.
3. Portnoy DA, Auerbuch V, Glomski IJ. 2002. The cell biology of Listeria monocytogenes infection: the intersection of bacterial pathogenesis and cell-mediated immunity. J. Cell Biol. 158:409-414. http://dx.doi.org/10 .1083/jcb.200205009.
4. Hamon M, Bierne H, Cossart P. 2006. Listeria monocytogenes: a multifaceted model. Nat. Rev. Microbiol. 4:423-434. http://dx.doi.org/10.1038/nrmicro1413.
5. Seki E, Tsutsui H, Tsuji NM, Hayashi N, Adachi K, Nakano H, Futatsugi-Yumikura S, Takeuchi O, Hoshino K, Akira S, Fujimoto J, Nakanishi K. 2002. Critical roles of myeloid differentiation factor 88-dependent proinflammatory cytokine release in early phase clearance of Listeria monocytogenes in mice. J. Immunol. 169:3863-3868.
6. Mancuso G, Gambuzza M, Midiri A, Biondo C, Papasergi S, Akira S, Teti G, Beninati C. 2009. Bacterial recognition by TLR7 in the lysosomes of conventional dendritic cells. Nat. Immunol. 10:587-594. http://dx.doi.org/10.1038/ni.1733.
7. Woodward JJ, Iavarone AT, Portnoy DA. 2010. c-di-AMP secreted by intracellular Listeria monocytogenes activates a host type I interferon response. Science 328:1703-1705. http://dx.doi.org/10.1126/science.1189801.
8. Sauer J-D, Sotelo-Troha K, von Moltke, J, Monroe KM, Rae CS, Brubaker SW, Hyodo M, Hayakawa Y, Woodward JJ, Portnoy DA, Vance RE. 2011. The N-ethyl-N-nitrosourea-induced Goldenticket mouse mutant reveals an essential function of Sting in the in vivo interferon response to Listeria monocytogenes and cyclic dinucleotides. Infect. Immun. 79:688-694. http://dx.doi.org/10.1128/IAI.00999-10.
9. O'Riordan M, Yi CH, Gonzales R, Lee KD, Portnoy DA. 2002. Innate recognition of bacteria by a macrophage cytosolic surveillance pathway. Proc. Natl. Acad. Sci. U. S. A. 99:13861-13866. http://dx.doi.org/10.1073 /pnas.202476699.
10. Stockinger S, Materna T, Stoiber D, Bayr L, Steinborn R, Kolbe T, Unger H, Chakraborty T, Levy DE, Muller M, Decker T. 2002. Production of type I IFN sensitizes macrophages to cell death induced by Listeria monocytogenes. J. Immunol. 169:6522-6529.
11. Levy DE, Darnell JE, Jr. 2002. Stats: transcriptional control and biological impact. Nat. Rev. Mol. Cell Biol. 3:651-662. http://dx.doi.org/10.1038 /nrm909.
12. Toshchakov V, Jones BW, Perera PY, Thomas K, Cody MJ, Zhang S, Williams BR, Major J, Hamilton TA, Fenton MJ, Vogel SN. 2002. TLR4, but not TLR2, mediates IFN-beta-induced STAT1alpha/beta-dependent gene expression in macrophages. Nat. Immunol. 3:392-398. http://dx.doi.org/10.1038/ni774.
13. McCaffrey RL, Fawcett P, O'Riordan M, Lee KD, Havell EA, Brown PO, Portnoy DA. 2004. A specific gene expression program triggered by Gram-positive bacteria in the cytosol. Proc. Natl. Acad. Sci. U. S. A. 101: 11386-11391. http://dx.doi.org/10.1073/pnas.0403215101.
14. Gao JJ, Filla MB, Fultz MJ, Vogel SN, Russell SW, Murphy WJ. 1998. Autocrine/paracrine IFN-alphabeta mediates the lipopolysaccharideinduced activation of transcription factor Stat1alpha in mouse macrophages: pivotal role of Stat1alpha in induction of the inducible nitric oxide synthase gene. J. Immunol. 161:4803-4810.
15. Bogdan C. 2001. Nitric oxide and the immune response. Nat. Immunol. 2:907-916. http://dx.doi.org/10.1038/ni1001-907.
16. Farlik M, Reutterer B, Schindler C, Greten F, Vogl C, Muller M, Decker T. 2010. Nonconventional initiation complex assembly by STAT and NFkappaB transcription factors regulates nitric oxide synthase expression. Immunity 33:25-34. http://dx.doi.org/10.1016/j.immuni.2010.07.001.
17. MacMicking JD, Nathan C, Hom G, Chartrain N, Fletcher DS, Trumbauer M, Stevens K, Xie QW, Sokol K, Hutchinson N, Chen H, Mudget JS. 1995. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 81:641-650. (Erratum, 81:following 1170.)
18. Fehr T, Schoedon G, Odermatt B, Holtschke T, Schneemann M, Bachmann MF, Mak TW, Horak I, Zinkernagel RM. 1997. Crucial role of interferon consensus sequence binding protein, but neither of interferon regulatory factor 1 nor of nitric oxide synthesis for protection against murine listeriosis. J. Exp. Med. 185:921-931. http://dx.doi.org/10.1084 /jem.185.5.921.
19. Stockinger S, Decker T. 2008. Novel functions of type I interferons revealed by infection studies with Listeria monocytogenes. Immunobiology 213:889-897. http://dx.doi.org/10.1016/j.imbio.2008.07.020.
20. Cole C, Thomas S, Filak H, Henson PM, Lenz LL. 2012. Nitric oxide increases susceptibility of Toll-like receptor-activated macrophages to spreading Listeria monocytogenes. Immunity 36:807-820. http://dx.doi.org/10.1016/j.immuni.2012.03.011.
21. Smale ST. 2012. Transcriptional regulation in the innate immune system. Curr. Opin. Immunol. 24:51-57. http://dx.doi.org/10.1016/j.coi.2011.12.008.
22. Adelman K, Lis JT. 2012. Promoter-proximal pausing of RNA polymerase II: emerging roles in metazoans. Nat. Rev. Genet. 13:720-731. http: //dx.doi.org/10.1038/nrg3293.
23. Nechaev S, Adelman K. 2011. Pol II waiting in the starting gates: regulating the transition from transcription initiation into productive elonga-tion. Biochim. Biophys. Acta 1809:34-45. http://dx.doi.org/10.1016/j.bbagrm.2010.11.001.
24. Medzhitov R, Horng T. 2009. Transcriptional control of the inflammatory response. Nat. Rev. Immunol. 9:692-703. http://dx.doi.org/10.1038 /nri2634.
25. Egloff S, Murphy S. 2008. Cracking the RNA polymerase II CTD code. Trends Genet. 24:280-288. http://dx.doi.org/10.1016/j.tig.2008.03.008.
26. Dey A, Chitsaz F, Abbasi A, Misteli T, Ozato K. 2003. The double bromodomain protein Brd4 binds to acetylated chromatin during interphase and mitosis. Proc. Natl. Acad. Sci. U. S. A. 100:8758-8763. http://dx.doi.org/10.1073/pnas.1433065100.
27. Yang Z, Yik JHN, Chen R, He N, Jang MK, Ozato K, Zhou Q. 2005. Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein Brd4. Mol. Cell 19:535-545. http://dx.doi.org /10.1016/j.molcel.2005.06.029.
28. Jang MK, Mochizuki K, Zhou M, Jeong H-S, Brady JN, Ozato K. 2005. The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulatesRNApolymerase II-dependent transcription. Mol. Cell 19:523-534. http://dx.doi.org/10.1016/j.molcel.2005.06.027.
29. Wu S-Y, Chiang C-M. 2007. The double bromodomain-containing chromatin adaptor Brd4 and transcriptional regulation. J. Biol. Chem. 282: 13141-13145. http://dx.doi.org/10.1074/jbc.R700001200.
30. Bisgrove DA, Mahmoudi T, Henklein P, Verdin E. 2007. Conserved P-TEFb-interacting domain of BRD4 inhibits HIV transcription. Proc. Natl. Acad. Sci. U. S. A. 104:13690-13695. http://dx.doi.org/10.1073/pnas.0705053104.
31. Hargreaves DC, Horng T, Medzhitov R. 2009. Control of inducible gene expression by signal-dependent transcriptional elongation. Cell 138:129- 145. http://dx.doi.org/10.1016/j.cell.2009.05.047.
32. Kanno T, Kanno Y, Siegel RM, Jang MK, Lenardo MJ, Ozato K. 2004. Selective recognition of acetylated histones by bromodomain proteins visualized in living cells. Mol. Cell 13:33-43. http://dx.doi.org/10.1016 /S1097-2765(03)00482-9.
33. LeRoy G, Rickards B, Flint SJ. 2008. The double bromodomain proteins Brd2 and Brd3 couple histone acetylation to transcription. Mol. Cell 30: 51-60. http://dx.doi.org/10.1016/j.molcel.2008.01.018.
34. Denis GV, Vaziri C, Guo N, Faller DV. 2000. RING3 kinase transactivates promoters of cell cycle regulatory genes through E2F. Cell Growth Differ. 11:417-424.
35. Wu F, Dassopoulos T, Cope L, Maitra A, Brant SR, Harris ML, Bayless TM, Parmigiani G, Chakravarti S. 2007. Genome-wide gene expression differences in Crohn's disease and ulcerative colitis from endoscopic pinch biopsies: insights into distinctive pathogenesis. Inflamm. Bowel Dis. 13:807-821. http://dx.doi.org/10.1002/ibd.20110.
36. Huang B, Yang X-D, Zhou M-M, Ozato K, Chen L-F. 2009. Brd4 coactivates transcriptional activation of NF-kappaB via specific binding to acetylated RelA. Mol. Cell. Biol. 29:1375-1387. http://dx.doi.org/10.1128 /MCB.01365-08.
37. Ramirez-Carrozzi VR, Braas D, Bhatt DM, Cheng CS, Hong C, Doty KR, Black JC, Hoffmann A, Carey M, Smale ST. 2009. A unifying model for the selective regulation of inducible transcription by CpG islands and nucleosome remodeling. Cell 138:114-128. http://dx.doi.org/10.1016/j.cell.2009.04.020.
38. Paulson M, Press C, Smith E, Tanese N, Levy DE. 2002. IFN-stimulated transcription through a TBP-free acetyltransferase complex escapes viral shutoff. Nat. Cell Biol. 4:140-147. http://dx.doi.org/10.1038/ncb747.
39. Jamieson AM, Farlik M, Decker T. 2012. How Stats interact with the molecular machinery of transcriptional activation, p 65-89. In Decker T, M̈ ullerM(ed), Jak-Stat signaling: from basics to disease. Springer, Vienna, Austria.
40. Nicodeme E, Jeffrey KL, Schaefer U, Beinke S, Dewell S, Chung C-W, Chandwani R, Marazzi I, Wilson P, Coste H, White J, Kirilovsky J, Rice CM, Lora JM, Prinjha RK, Lee K, Tarakhovsky A. 2010. Suppression of inflammation by a synthetic histone mimic. Nature 468:1119-1123. http: //dx.doi.org/10.1038/nature09589.
41. Belkina AC, Nikolajczyk BS, Denis GV. 2013. BET protein function is required for inflammation: Brd2 genetic disruption and BET inhibitor JQ1 impair mouse macrophage inflammatory responses. J. Immunol. 190: 3670-3678. http://dx.doi.org/10.4049/jimmunol.1202838.
42. Patel MC, Debrosse M, Smith M, Dey A, Huynh W, Sarai N, Heightman TD, Tamura T, Ozato K. 2013. BRD4 coordinates recruitment of pause-release factor P-TEFb and the pausing complex NELF/DSIF to regulate transcription elongation of interferon stimulated genes. Mol. Cell. Biol. 33:2497-2507. http://dx.doi.org/10.1128/MCB.01180-12.
43. Tian B, Zhao Y, Kalita M, Edeh CB, Paessler S, Casola A, Teng MN, Garofalo RP, Brasier AR. 2013. CDK9-dependent transcriptional elongation in the innate ISG response to RSV infection in airway epithelial cells. J. Virol. 87:7075-7092. http://dx.doi.org/10.1128/JVI.03399-12.
44. Filippakopoulos P, Qi J, Picaud S, Shen Y, Smith WB, Fedorov O, Morse EM, Keates T, Hickman TT, Felletar I, Philpott M, Munro S, McKeown MR, Wang Y, Christie AL, West N, Cameron MJ, Schwartz B, Heightman TD, La Thangue N, French CA, Wiest O, Kung AL, Knapp S, Bradner JE. 2010. Selective inhibition of BET bromodomains. Nature 468:1067-1073. http://dx.doi.org/10.1038/nature09504.
45. Baccarini M, Bistoni F, Lohmann Matthes ML. 1985. In vitro natural cell-mediated cytotoxicity against Candida albicans: macrophage precursors as effector cells. J. Immunol. 134:2658-2665.
46. Stockinger S, Reutterer B, Schaljo B, Schellack C, Brunner S, Materna T, Yamamoto M, Akira S, Taniguchi T, Murray PJ, Muller M, Decker T. 2004. IFN regulatory factor 3-dependent induction of type I IFNs by intracellular bacteria is mediated by a TLR- and Nod2-independent mechanism. J. Immunol. 173:7416-7425.
47. Meyer FRL, Grausgruber H, Binter C, Mair GE, Guelly C, Vogl C, Steinborn R. 2013. Cross-platform microarray meta-analysis for the mouse jejunum selects novel reference genes with highly uniform levels of expression. PLoS One 8:e63125. http://dx.doi.org/10.1371/journal.pone.0063125.
48. Zuber J, McJunkin K, Fellmann C, Dow LE, Taylor MJ, Hannon GJ, Lowe SW. 2011. Toolkit for evaluating genes required for proliferation and survival using tetracycline-regulated RNAi. Nat. Biotechnol. 29:79-83 http://dx.doi.org/10.1038/nbt.1720.
49. Hochedlinger K, Yamada Y, Beard C, Jaenisch R. 2005. Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues. Cell 121:465-477. http://dx.doi.org/10.1016/j.cell.2005.02.018.
50. Serbina NV, Salazar-Mather TP, Biron CA, Kuziel WA, Pamer EG. 2003. TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection. Immunity 19:59-70. http://dx.doi.org/10.1016/S1074-7613(03)00171-7.
51. Clark K, Peggie M, Plater L, Sorcek RJ, Young ERR, Madwed JB, Hough J, McIver EG, Cohen P. 2011. Novel cross-talk within the IKK family controls innate immunity. Biochem. J. 434:93-104. http://dx.doi.org/10.1042/BJ20101701.
52. Chen LF, Greene WC. 2004. Shaping the nuclear action of NF-kappaB. Nat. Rev. Mol. Cell Biol. 5:392-401. http://dx.doi.org/10.1038/nrm1368.
53. Dai Y, Rahmani M, Dent Grant PS. 2005. Blockade of histone deacetylase inhibitor-induced RelA/p65 acetylation and NF-kappaB activation potentiates apoptosis in leukemia cells through a process mediated by oxidative damage, XIAP downregulation, and c-Jun N-terminal kinase 1 activation. Mol. Cell. Biol. 25:5429-5444. http://dx.doi.org/10.1128/MCB.25.13.5429-5444.2005.
54. Yeung F, Hoberg JE, Ramsey CS, Keller MD, Jones DR, Frye RA, Mayo MW. 2004. Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J. 23:2369-2380. http://dx.doi.org/10.1038/sj.emboj.7600244.
55. Matkar S, Thiel A, Hua X. 2013. Menin: a scaffold protein that controls gene expression and cell signaling. Trends Biochem. Sci. 38:394-402. http://dx.doi.org/10.1016/j.tibs.2013.05.005.
56. Brasier AR, Tian B, Jamaluddin M, Kalita MK, Garofalo RP, Lu M. 2011. RelA Ser276 phosphorylation-coupled Lys310 acetylation controls transcriptional elongation of inflammatory cytokines in respiratory syncytial virus infection. J. Virol. 85:11752-11769. http://dx.doi.org/10.1128 /JVI.05360-11.
57. Peterlin BMB, Price DHD. 2006. Controlling the elongation phase of transcription with P-TEFb. Mol. Cell 23:297-305. http://dx.doi.org/10.1016/j.molcel.2006.06.014.
58. Pfeffer K, Matsuyama T, Kundig TM, Wakeham A, Kishihara K, Shahinian A, Wiegmann K, Ohashi PS, Kronke M, Mak TW. 1993. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73: 457-467.
59. Rossol-Voth R, Rossol S, Schütt KH, Corridori S, de Cian W, Falke D. 1991. In vivo protective effect of tumour necrosis factor alpha against experimental infection with herpes simplex virus type 1. J. Gen. Virol. 72:143-147. http://dx.doi.org/10.1099/0022-1317-72-1-143.
60. Van Hauwermeiren F, Armaka M, Karagianni N, Kranidioti K, Vandenbroucke RE, Loges S, Van Roy M, Staelens J, Puimège L, Palagani A, Berghe WV, Victoratos P, Carmeliet P, Libert C, Kollias G. 2013. Safe TNF-based antitumor therapy following p55TNFR reduction in intestinal epithelium. J. Clin. Invest. 123:2590-2603. http://dx.doi.org/10.1172 /JCI65624.
61. Jamieson AM, Pasman L, Yu S, Gamradt P, Homer RJ, Decker T, Medzhitov R. 2013. Role of tissue protection in lethal respiratory viralbacterial coinfection. Science 340:1230-1234. http://dx.doi.org/10.1126 /science.1233632.
62. Jayasekera JP, Vinuesa CG, Karupiah G, King NJC. 2006. Enhanced antiviral antibody secretion and attenuated immunopathology during influenza virus infection in nitric oxide synthase-2-deficient mice. J. Gen. Virol. 87:3361-3371. http://dx.doi.org/10.1099/vir.0.82131-0.
63. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F. 2004. Recognition of commensal microflora by Toll-like receptors is required for intestinalhomeostasis. Cell 118:229-241. http://dx.doi.org/10.1016/j.cell.2004.07.002.
64. Kirkland D, Benson A, Mirpuri J, Pifer R, Hou B, DeFranco AL, Yarovinsky F. 2012. B cell-intrinsic MyD88 signaling prevents the lethal dissemination of commensal bacteria during colonic damage. Immunity 36:228-238. http://dx.doi.org/10.1016/j.immuni.2011.11.019.
65. Hoshi N, Schenten D, Nish SA, Walther Z, Gagliani N, Flavell RA, Reizis B, Shen Z, Fox JG, Iwasaki A, Medzhitov R. 2012. MyD88 signalling in colonic mononuclear phagocytes drives colitis in IL-10-deficient mice. Nat. Commun. 3:1120. http://dx.doi.org/10.1038/ncom ms2113.
66. Smith E, Lin C, Shilatifard A. 2011. The super elongation complex (SEC) and MLL in development and disease. Genes Dev. 25:661-672. http://dx.doi.org/10.1101/gad.2015411.
67. Malik S, Roeder RG. 2010. The metazoan Mediator co-activator complex as an integrative hub for transcriptional regulation. Nat. Rev. Genet. 11: 761-772. http://dx.doi.org/10.1038/nrg2901.
68. Conaway RC, Conaway JW. 2013. The Mediator complex and transcription elongation. Biochim. Biophys. Acta 1829:69-75. http://dx.doi.org/10.1016/j.bbagrm.2012.08.017.
69. Donner AJ, Ebmeier CC, Taatjes DJ, Espinosa JM. 2010. CDK8 is a positive regulator of transcriptional elongation within the serum response network. Nat. Struct. Mol. Biol. 17:194-201. http://dx.doi.org/10.1038 /nsmb.1752.
70. Takahashi H, Parmely TJ, Sato S, Tomomori-Sato C, Banks CAS, Kong SE, Szutorisz H, Swanson SK, Martin-Brown S, Washburn MP, Florens L, Seidel CW, Lin C, Smith ER, Shilatifard A, Conaway RC, Conaway JW. 2011. Human mediator subunit MED26 functions as a docking site for transcription elongation factors. Cell 146:92-104. http://dx.doi.org/10.1016/j.cell.2011.06.005.
71. Devaiah BN, Singer DS. 2012. Cross-talk among RNA polymerase II kinases modulates C-terminal domain phosphorylation. J. Biol. Chem. 287:38755-38766. http://dx.doi.org/10.1074/jbc.M112.412015.
72. Dalrymple SA, Lucian LA, Slattery R, McNeil T, Aud DM, Fuchino S, Lee F, Murray R. 1995. Interleukin-6-deficient mice are highly susceptible to Listeria monocytogenes infection: correlation with inefficient neutrophilia. Infect. Immun. 63:2262-2268.
73. Labow M, Shuster D, Zetterstrom M, Nunes P, Terry R, Cullinan EB, Bartfai T, Solorzano C, Moldawer LL, Chizzonite R, McIntyre KW. 1997. Absence of IL-1 signaling and reduced inflammatory response in IL-1 type I receptor-deficient mice. J. Immunol. 159:2452-2461.
74. Eckmann L, Nebelsiek T, Fingerle AA, Dann SM, Mages J, Lang R, Robine S, Kagnoff MF, Schmid RM, Karin M, Arkan MC, Greten FR. 2008. Opposing functions of IKKbeta during acute and chronic intestinal inflammation. Proc. Natl. Acad. Sci. U. S. A. 105:15058-15063. http://dx.doi.org/10.1073/pnas.0808216105.
75. Liu SF, Malik AB. 2006. NF-kappa B activation as a pathological mechanism of septic shock and inflammation. Am. J. Physiol. Lung Cell. Mol. Physiol. 290:L622-L645. http://dx.doi.org/10.1152/ajplung.00477.2005.
76. Delmore JE, Issa GC, Lemieux ME, Rahl PB, Shi J, Jacobs HM, Kastritis E, Gilpatrick T, Paranal RM, Qi J, Chesi M, Schinzel AC, McKeown MR, Heffernan TP, Vakoc CR, Bergsagel PL, Ghobrial IM, Richardson PG, Young RA, Hahn WC, Anderson KC, Kung AL, Bradner JE, Mitsiades CS. 2011. BET bromodomain inhibition as a therapeutic strategy to target c-Myc. Cell 146:904-917. http://dx.doi.org/10.1016/j.cell.2011.08.017.
77. Zuber J, Shi J, Wang E, Rappaport AR, Herrmann H, Sison EA, Magoon D, Qi J, Blatt K, Wunderlich M, Taylor MJ, Johns C, Chicas A, Mulloy JC, Kogan SC, Brown P, Valent P, Bradner JE, Lowe SW, Vakoc CR. 2011. RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia. Nature 478:524-528. http://dx.doi.org/10.1038 /nature10334.
78. Matzuk MM, McKeown MR, Filippakopoulos P, Li Q, Ma L, Agno JE, Lemieux ME, Picaud S, Yu RN, Qi J, Knapp S, Bradner JE. 2012. Small-molecule inhibition ofBRDTfor male contraception. Cell 150:673- 684. http://dx.doi.org/10.1016/j.cell.2012.06.045.
79. Ott CJ, Kopp N, Bird L, Paranal RM, Qi J, Bowman T, Rodig SJ, Kung AL, Bradner JE, Weinstock DM. 2012. BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia. Blood 120:2843-2852. http://dx.doi.org/10.1182/blood-2012-02-413021.